Navigation Links
ERT Reports First Quarter 2009 Results
Date:4/30/2009

- - Common stock-$.01 par value, 175,000,000 shares authorized, 59,950,257 and 59,974,108 shares issued, respectively 600 600 Additional paid-in capital 93,828 94,826 Accumulated other comprehensive income (2,716) (2,948) Retained earnings 110,479 112,549 Treasury stock, 8,686,868 and 10,652,320 shares at cost, respectively (64,763) (74,755) Total stockholders' equity 137,428 130,272 Total liabilities and stockholders' equity $169,122 $158,267


                     eResearchTechnology, Inc. and Subsidiaries
                        Consolidated Statements of Cash Flows
                                   (in thousands)
                                     (unaudited)

                                                Three Months Ended March 31,
                                                    2008              2009

    Operating activities:
      Net income                                  $5,746            $2,070
      Adjustments to reconcile net income
       to net cash provided by operating
       activities:
        Depreciation and amortization              4,344             3,404
        Cost of sales of equipment                   414                 7
        Provision for uncollectible accounts          30               105
        Share-based compensation                     470               901
        Deferred income taxes                       (362)              111
        Changes in operating assets and
         liabilities:
          Accounts receivable                       (222)             7,331
          Prepaid expenses and other                 (11)             
'/>"/>
SOURCE eResearchTechnology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. CryoLife Reports Record First Quarter Revenues of $26.7 Million
2. Caliper Life Sciences Reports First Quarter 2009 Results
3. Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets
4. ViroPharma Incorporated Reports First Quarter 2009 Financial Results
5. Vanda Pharmaceuticals Reports First Quarter 2009 Results
6. Telik Reports Preclinical Results at AACR Annual Meeting
7. PAREXEL Reports Third Quarter Fiscal Year 2009 Financial Results
8. Peregrine Pharmaceuticals Reports Positive Data in Second Phase II Bavituximab Breast Cancer Trial
9. Sinobiopharma Reports a 141% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
10. Sinobiopharma Reports a 41% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
11. Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... 2014 An analysis by Replikins, Ltd. of ... Mers CoV virus strains has revealed extensive conservation ... This conservation and sharing of specific Replikin gene structures ... candidate, as it did for the H5N1 influenza vaccine ... have been found to be effective (1,2). ...
(Date:8/26/2014)... , August 26, 2014 , ... hospitals with surgery validation using its Stratasys Objet24 and Objet30 ... surgery on 3D printed models prior to operations reduces theatre ... effective aid for both patient and surgeon   ... a global leader of 3D printing and additive manufacturing solutions, ...
(Date:8/26/2014)... AVENTURA. Fla. , Aug. 26, 2014 /PRNewswire/ ... trades under the symbol (NUUU) has two (2) ... Inc. Our two subsidiaries harness scientifically advanced technology ... NUUU,s Renuell Int,l, Inc. ... breakthrough anti-aging skin care products that is made ...
(Date:8/26/2014)... , Aug. 26, 2014 Trovagene, Inc. ... Generation Dx Summit; Moving Assays to the Clinic ... and Monitoring of Cell Free Tumor DNA in ... component of its Precision Cancer Monitoring (PCM) platform ... sensitivity for the detection of tumor DNA mutations ...
Breaking Biology Technology:Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 2Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 3Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 4Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 5Technology Applications International Corporation, Trading Symbol NUUU now trading on NASDAQ's Over the Counter Bulletin Board (OTC BB) 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4
... The Renewable Energy ... promising locations for renewable energy projects. ,The Atlas is the first tool of its kind ... select from a suite of renewable energy options including biomass, efficiency, geothermal, hydroelectric, solar and ... (PRWEB) ...
... ... Environmental Sustainability (EStar) award from the U.S. Department of Energy,s (DOE) Office of Science. ... Argonne, ... Gene/P supercomputer was recognized with an Environmental Sustainability (EStar) award from the U.S. Department ...
... ... of 2007 and to enhance patient safety with complete part traceability, can now use ... coding, scan and software tracking of each part and batch, including all leak test, ... ...
Cached Biology Technology:Vermont Launches Renewable Energy Atlas 2Vermont Launches Renewable Energy Atlas 3Vermont Launches Renewable Energy Atlas 4EStar Award Recognizes Innovative Supercomputer Cooling 2EStar Award Recognizes Innovative Supercomputer Cooling 3InterTech Development Company UDI System Announced 2
(Date:8/25/2014)... predominant strain of community-acquired methicillin-resistant Staphylococcus aureus ... East and northern Africa derived from a single ... this week in mBio , the online ... , CA-MRSA refers to MRSA infections occurring in ... which are typically skin infections, can be transmitted ...
(Date:8/25/2014)... deficiency is one of the most widespread causes of ... the United States are plagued by boron deficient soil ... supplement their soil with boron; however, little is known ... essential nutrient. Now, researchers at the University of Missouri ... development and reproduction in corn plants. Scientists anticipate that ...
(Date:8/25/2014)... that toxic effects of substances known as endocrine ... human-made materials, can pass from one generation to ... with ancestral exposure to EDC may show especially ... new study by researchers from The University of ... and female rats are affected differently by ancestral ...
Breaking Biology News(10 mins):Common European MRSA originated in Africa 2Researchers find boron facilitates stem cell growth and development in corn 2Exposure to toxins makes great granddaughters more susceptible to stress 2
... CITY People at risk for a certain form of ... better chance at surviving or even avoiding the diseases, thanks ... Institute at LDS Hospital. The Intermountain Heathcare group of ... cost-effective way to identify patients who may have Lynch syndrome, ...
... of researchers at the Department of Energy,s BioEnergy Science ... controls ethanol production capacity in a microorganism. This discovery ... that produce higher concentrations of ethanol at lower costs. ... the scientific discoveries of its labs and research centers ...
... study by an international team including professor John Graves of ... species of tunas and billfishes are threatened and in need ... issue of Science magazine,s Policy Forumis the first ... of the International Union for Conservation of Nature (IUCN). ,The ...
Cached Biology News:Study: New process that can save at-risk cancer patients is effective and significantly less costly 2Study: New process that can save at-risk cancer patients is effective and significantly less costly 3Single, key gene discovery could streamline production of biofuels 2Study helps assess global status of tuna and billfish stocks 2Study helps assess global status of tuna and billfish stocks 3